Results 41 to 50 of about 567,985 (207)
Medicina, 2023 Background: Atrial flutter is an infrequent yet potentially fatal arrhythmia. Digoxin is the preferred first-line treatment for fetal atrial flutter due to its efficacy and favorable safety profile.
Soo Jung Kim +5 more
doaj +1 more source
Oromucosal Alginate Films with Zein Nanoparticles as a Novel Delivery System for Digoxin
Pharmaceutics, 2021 Digoxin is a hydrophobic drug used for the treatment of heart failure that possesses a narrow therapeutic index, which raises safety concerns for toxicity. This is of utmost relevance in specific populations, such as the elderly.
Daniela A. Rodrigues +5 more
doaj +1 more source
Journal of Family Medicine and Primary CareDigoxin, a cardiac glycoside, functions by inhibiting the sodium potassium ATPase pump. It’s crucial to note that digoxin has a very narrow therapeutic range. Its serum level vary due to changes in body weight, age, renal function, hepatic impairment and
Rajathadri H. Ravikumar +3 more
doaj +1 more source
Practical Laboratory Medicine, 2022 Vancomycin and digoxin are associated with potential toxicity and serum concentrations need to be monitored in certain patients. Previous reports suggested IgM paraproteins could interfere with vancomycin assays, and no paraprotein interference has been ...
Nga Yeung Tang +4 more
doaj +1 more source
Study the toxicity of digoxin on liver and their transaminase enzymes level in rat
Kufa Journal for Veterinary Medical Sciences, 2017 The current study was conducted at the college of veterinary medicine, university of basrah in the periods extended from 22/10/2016 to 22/1/2017. Digoxin is an important cause of poisoning. It is prescribed and widely used to patients with heart failure.
Abbas Khadhair, Saleh Majeed
doaj +1 more source
Severe digoxin intoxication: A case report of the use of digoxin-specific Fab antibody fragments
Zdravniški Vestnik, 2023 Digoxin is a cardiac glycoside that has been used for several decades to treat heart failure and atrial fibrillation. Several doctors prescribe it to their patients, although it is not the first choice for either condition.
Tadej Petreski +4 more
doaj +1 more source
Safety and Feasibility of Magnetic Separation‐Based Blood Purification
Advanced NanoBiomed Research, EarlyView.We present the preclinical biological safety and translational feasibility of a magnetic nanoparticle‐based extracorporeal blood purification platform for removal of disease‐causing blood factors. ISO 10993‐compliant studies and exaggerated worst‐case exposure models demonstrate efficient nanoparticle extraction (≥99.9%), favorable biocompatibility ...
Carlos A. Mora +11 more
wiley +1 more source
A case report on digoxin toxicity [PDF]
Digoxin is an inotropic drug that is commonly prescribed in patient with heart related diseases. The effective dose of digoxin is 0.8-2.0 ng/ml beyond which digoxin causes toxic effects like visual dysfunction, irregular heartbeat, and cardiovascular ...
Jabeen, Raqshan +2 more
core +1 more source
British Journal of Clinical Pharmacology, EarlyView.Aims To quantify prescribing adherence to renal dosing recommendations in adults with chronic kidney disease (CKD; Stage 3 and above) and to evaluate the clinical consequences of non‐adherence. Methods This systematic review and meta‐analysis was conducted in accordance with PRISMA 2020 guidelines and registered in PROSPERO (CRD42025620883).
Hager ElGeed +7 more
wiley +1 more source
Preparation of Nanoparticles of Digoxin Solid Lipid
Chemical Engineering Transactions, 2017 In order to prove the role of solid lipid nanoparticles in oral absorption and bioavailability, the biodegradable monoglyceride with low toxicity and good biocompatibility is used as lipid materials to prepare nanoparticles of digoxin solid lipid and ...
Ping Luo, Yangwu Liu
doaj +1 more source